News · 26 weeks25+125%
2025-12-142026-06-07
Mix1790d
- Insider9(53%)
- SEC Filings4(24%)
- Other3(18%)
- Leadership1(6%)
Latest news
25 items- INSIDERDirector Eitan Yaron returned 50,000 shares to the company and was granted 175,000 shares, decreasing direct ownership by 4% to 1,224,073 units (SEC Form 4)4 - Marpai, Inc. (0001844392) (Issuer)
- INSIDERChief Financial Officer Johnson Steve Andrew was granted 125,000 shares and bought $682 worth of shares (1,100 units at $0.62), increasing direct ownership by 14% to 1,024,192 units (SEC Form 4)4 - Marpai, Inc. (0001844392) (Issuer)
- INSIDERDirector Shiv Sagiv returned 50,000 shares to the company and was granted 125,000 shares, decreasing direct ownership by 8% to 613,667 units (SEC Form 4)4 - Marpai, Inc. (0001844392) (Issuer)
- INSIDERDirector Pons Robert M returned 50,000 shares to the company and was granted 100,000 shares, decreasing direct ownership by 9% to 484,200 units (SEC Form 4)4 - Marpai, Inc. (0001844392) (Issuer)
- INSIDERDirector Calabrese Jennifer Rosario returned 50,000 shares to the company and was granted 100,000 shares, decreasing direct ownership by 18% to 225,000 units (SEC Form 4)4 - Marpai, Inc. (0001844392) (Issuer)
- INSIDERChief Executive Officer Lamendola Damien was granted 300,000 shares, increasing direct ownership by 22% to 1,650,000 units (SEC Form 4)4 - Marpai, Inc. (0001844392) (Issuer)
- INSIDERDirector Diclaudio Colleen was granted 125,000 shares, increasing direct ownership by 88% to 267,500 units (SEC Form 4)4 - Marpai, Inc. (0001844392) (Issuer)
- PRMarpai Inc. Announces Unprecedented Growth with 192,000 New Estimated Member Lives Across TPA and MarpaiRx PBM Platforms; Expects to Achieve Positive Cash Flow and EBITDA Beginning August 2026TAMPA, Fla., May 26, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Third-Party Administration ("TPA"), and Pharmacy Benefit Management ("PBM") services, today announced a historic expansion of its business book. Following a series of newly secured commitments and confirmed new business across its Third-Party Administrator (TPA) and MarpaiRx Pharmacy Benefit Management (PBM) platforms, the Company estimates a total increase of 192,000 member lives scheduled to roll out between August 2026 and January 2027.This influx represents a nearly six-fold increase in the Company's current member lives, potentially transforming
- INSIDERDirector Eitan Yaron bought $2,700 worth of shares (10,000 units at $0.27), increasing direct ownership by 0.92% to 1,099,073 units (SEC Form 4)4 - Marpai, Inc. (0001844392) (Issuer)
- SECSEC Form 10-Q filed by Marpai Inc.10-Q - Marpai, Inc. (0001844392) (Filer)
- PRMARPAI REPORTS FIRST QUARTER 2026 FINANCIAL RESULTSStrategic Investments in Operations and Technology Fuel Platform for Accelerated Growth and Aim of Second-Half 2026 ProfitabilityTAMPA, Fla., May 15, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Third-Party Administration (TPA), and Pharmacy Benefit Management ("PBM") services, announced the financial results for the first quarter 2026.Marpai's first quarter 2026 results reflect the Company's continued execution of its operational transformation designed to position the business for profitability and growth. The Company has nearly completed the migration of its IT and claims processing to a single, unified cloud-bas
- PRMarpai, Inc. Announces Significant New Business Wins across TPA and MarpaiRx; Solidifies Forecast for ProfitabilityTAMPA, Fla., May 11, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Third-Party Administration ("TPA"), and Pharmacy Benefit Management ("PBM") services, today announced several significant new business wins across its core TPA and MarpaiRx divisions. These new client wins, representing a diverse range of self-insured employer groups, are expected to be primary drivers in the Company's path toward achieving sustained profitability.Pursuant to the newly secured contracts, Marpai is expected to provide comprehensive TPA services and integrated pharmacy benefit management services through MarpaiRx, reflect the growing de
- SECMarpai Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - Marpai, Inc. (0001844392) (Filer)
- INSIDERSEC Form 4 filed by Shiv Sagiv4 - Marpai, Inc. (0001844392) (Issuer)
- PRMarpai, Inc. Secures Major Strategic Marketing Collaboration to Continue Acceleration of MarpaiRx Growth NationwideTAMPA, Fla., April 1, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Third-Party Administration (TPA), and Pharmacy Benefit Management (PBM) services, today announced the execution of what the Company believes is its largest to date definitive marketing agreement with a leading healthcare solutions provider. This strategic collaboration is designed to scale the reach of MarpaiRx, Marpai's pharmacy benefit management (PBM) services, across a vast network of self-insured employer groups and third-party administrators.Under the terms of the three-year agreement, the team will leverage its extensive domestic and internati
- SECSEC Form 10-K filed by Marpai Inc.10-K - Marpai, Inc. (0001844392) (Filer)
- SECMarpai Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - Marpai, Inc. (0001844392) (Filer)
- PRMarpai Secures Access to Network Creating Major Growth Catalyst for MarpaiRx Representing Up to 1.5 million Covered LivesMarketing Agreement Establishes Powerful National Distribution Channel and Expands Marpai's Revenue Growth OpportunityTAMPA, Fla., March 9, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Third-Party Administration (TPA), and Pharmacy Benefit Management (PBM) services, today announced the execution of a transformational marketing agreement dramatically expanding the national reach of its high-growth pharmacy benefit management division, providing access to a network representing up to 1.5 million covered employees for MarpaiRx.The agreement creates a powerful new distribution channel for MarpaiRx's pharmacy benefit sol
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Marpai Inc.SCHEDULE 13G/A - Marpai, Inc. (0001844392) (Subject)
- PRMarpai, Inc. Secures Major Strategic Wins for MarpaiRx, Adding Over 19,000 Lives and Accelerating High-Growth Platform ExpansionNew Client Momentum Highlights Rapid Adoption of Marpai's Disruptive, Scalable Healthcare Platform Positioned to Drive Exponential Revenue Growth and Long-Term Shareholder ValueTAMPA, Fla., Feb. 23, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Third-Party Administration (TPA), and Pharmacy Benefit Management (PBM) services, today announced two significant strategic client wins for its high-growth MarpaiRx division, adding more than 19,000 covered lives and further accelerating the Company's expansion as a next-generation healthcare platform.We believe that these wins represent strong validation of Marpai's different
- SECMarpai Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - Marpai, Inc. (0001844392) (Filer)
- PRMARPAI, INC. HIRES PHARMACY EXECUTIVE MIMI DAVIS AS PRESIDENT OF MARPAIRX TO DRIVE STRATEGIC GROWTHTAMPA, Fla., Jan. 27, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Pharmacy Benefit Management (PBM) and Third-Party Administration (TPA) services, announced the hiring of Mimi Davis as President of MarpaiRx. Davis, a distinguished leader in the pharmacy services sector, will oversee the strategic expansion and operational scaling of Marpai's pharmacy benefit offerings. Davis joins Marpai from Knipper Health, where she served as Executive Vice President of Operations. Her deep industry roots include a significant tenure at Eagle Pharmacy—a former HillCour portfolio company—which was acquired by Knipper in 2020. With
- SECMarpai Inc. filed SEC Form 8-K: Leadership Update, Entry into a Material Definitive Agreement8-K - Marpai, Inc. (0001844392) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Marpai Inc.SCHEDULE 13G/A - Marpai, Inc. (0001844392) (Subject)
- SECMarpai Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - Marpai, Inc. (0001844392) (Filer)
MRAI FAQ
6 questionsWhat does Marpai Inc. do?
Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market. It also offers ancillary services, such as care management, case management, actuarial services, health savings account administration, and cost containment services. The company was incorporated in 2021 and is based in Tampa, Florida.Where does MRAI stock trade?
Marpai Inc. (MRAI) is listed on NASDAQ.What sector and industry is MRAI in?
Marpai Inc. operates in the Health Care sector, Misc Health and Biotechnology Services industry.When did Marpai Inc. go public?
Marpai Inc. (MRAI) completed its IPO in 2021.What companies are similar to MRAI?
Notable peers in the same industry include DVA (DaVita Inc.), FMS (Fresenius Medical Care AG), SHC (Sotera Health Company), PGNY (Progyny Inc.), AGL (agilon health inc.). Compare MRAI side-by-side with any of them on Quantisnow.How can I track MRAI on Quantisnow?
Quantisnow aggregates Marpai Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MRAI to receive live email and push alerts on every new disclosure.